TissueMill Technologies LLC provides the TissueMil System, an automated and closed aseptic system for the atraumatic morsalization of full-thickness skin biopsies. The technology cuts tissue in an aqueous medium to produce high-quality micrografts with preserved native architecture and high cell viability for wound care applications.
Subscribe to see TissueMill Technologies LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
TissueMill Technologies LLC is a medical technology company headquartered in United States. Its most recent funding round raised $1M in April 2022. Xcout tracks 2 named people at TissueMill Technologies LLC, including Alain Klapholz (CO-FOUNDER & COO).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of TissueMill Technologies LLC's closest competitors — see the full list of competitors and alternatives →
Tiger Biotherapeutics Inc. is a regenerative medicine company that develops and provides advanced cellular, acellular, and matrix-like products (CAMPs) for wound care, aesthetics, and tissue science. The company serves healthcare providers and patients by offering solutions for tissue repair, wound closure, and reconstructive or cosmetic applications.
MedVital (MedVital Ventures Private Limited) is a medical technology company based in India. It focuses on developing innovative products and technologies for wound care, wound closure, tissue regeneration, and scar management.
Clarapath, Inc. is a U.S. medical-technology company developing robotic automation systems for anatomical pathology and histology workflows, including tissue processing and slide preparation. Its products are intended for hospital, clinical, and pathology laboratories to improve the efficiency and consistency of diagnostic specimen preparation.
AOTI, Inc. (Advanced Oxygen Therapy, Inc.) develops medical devices that deliver topical oxygen therapy, including systems used to support the healing of chronic and hard-to-heal wounds. Its products are used by healthcare providers and patients in wound-care settings.
Vivalyx develops "Omnisol," a patented, blood-free preservation solution designed to improve the viability and quality of donor organs for transplantation. The company serves the medical and transplant sector by supporting various organ preservation methods, including static cold storage and machine perfusion.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.